Cambridge Investment Research Advisors, Inc. Dynavax Technologies Corp Transaction History
Cambridge Investment Research Advisors, Inc.
- $27.1 Billion
- Q2 2024
A detailed history of Cambridge Investment Research Advisors, Inc. transactions in Dynavax Technologies Corp stock. As of the latest transaction made, Cambridge Investment Research Advisors, Inc. holds 11,290 shares of DVAX stock, worth $126,109. This represents 0.0% of its overall portfolio holdings.
Number of Shares
11,290
Previous 12,365
8.69%
Holding current value
$126,109
Previous $153,000
16.99%
% of portfolio
0.0%
Previous 0.0%
Shares
20 transactions
Others Institutions Holding DVAX
# of Institutions
259Shares Held
132MCall Options Held
371KPut Options Held
99.2K-
Black Rock Inc. New York, NY21.9MShares$245 Million0.01% of portfolio
-
Deep Track Capital, LP Greenwich, CT10.9MShares$122 Million4.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.37MShares$105 Million0.0% of portfolio
-
State Street Corp Boston, MA7.96MShares$88.9 Million0.0% of portfolio
-
Federated Hermes, Inc. Pittsburgh, PA7.15MShares$79.8 Million0.19% of portfolio
About DYNAVAX TECHNOLOGIES CORP
- Ticker DVAX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 126,474,000
- Market Cap $1.41B
- Description
- Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...